Researchers have discovered that breast cancer stem cells can shift between cell surface molecules CD44s and CD44v via alternative splicing and consequently alter their ability to survive.
Researchers have discovered that breast cancer stem cells can shift between cell surface molecules CD44s and CD44v via alternative splicing and consequently alter their ability to survive.